Correlation Between Pfizer and Akebia Ther

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Akebia Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Akebia Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Akebia Ther, you can compare the effects of market volatilities on Pfizer and Akebia Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Akebia Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Akebia Ther.

Diversification Opportunities for Pfizer and Akebia Ther

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Pfizer and Akebia is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Akebia Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akebia Ther and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Akebia Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akebia Ther has no effect on the direction of Pfizer i.e., Pfizer and Akebia Ther go up and down completely randomly.

Pair Corralation between Pfizer and Akebia Ther

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Akebia Ther. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 5.85 times less risky than Akebia Ther. The stock trades about -0.05 of its potential returns per unit of risk. The Akebia Ther is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  185.00  in Akebia Ther on December 28, 2024 and sell it today you would earn a total of  8.00  from holding Akebia Ther or generate 4.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Akebia Ther

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
Akebia Ther 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Akebia Ther are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental drivers, Akebia Ther sustained solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Akebia Ther Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Akebia Ther

The main advantage of trading using opposite Pfizer and Akebia Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Akebia Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akebia Ther will offset losses from the drop in Akebia Ther's long position.
The idea behind Pfizer Inc and Akebia Ther pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences